^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Multiple Myeloma
    Drug:Hemady (dexamethasone tablets) (GCR agonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    HEMADY is a corticosteroid indicated in combination with other antimyeloma products for the treatment of adults with multiple myeloma.